Items tagged with Medicines

MSF issue brief: Ready, set, slow down (post with simple image)

New and promising DR-TB drugs are grabbing headlines but not reaching patients.

Treating drug-sensitive TB in India: Implementation of daily therapy with fixed-dose combinations (post with simple image)

A briefing document outlines critical steps needed to implement a new policy from the Indian government to switch to standard daily TB treatment using fixed-dose combinations. This change, which is in line with global recommendations for proper treatment, is welcome but has yet to be put into action.

Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives (post with simple image)

This review outlines challenges in accessing drugs encountered from the perspective of clinicians, patients and affected communities, and offers potential solutions.

WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers (post with simple image)

New WHO Model List of Essential Medicines published; After about 45 years of scarce innovation for TB medicines, 5 new products are included in the List. Four of these, including bedaquiline and delamanid, target multidrug-resistant TB.

Treatment of drug-resistant TB with new and repurposed medications: A supplemental field guide for nurses (post with simple image)

The guide focuses on issues of importance to nurses and the types of care they provide to individuals with drug-resistant TB.

HIV i-Base/TAG: 2015 Pipeline Report (post with simple image)

Latest annual review on HIV, HCV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.

Tuberculosis in adults and children (post with simple image)

A monograph written for healthcare workers in any setting who are faced with the complex care for patients with tuberculosis.

Appeal to develop VXc-486 for tuberculosis (post with simple image)

Advocates urge Vertex to assure the timely and responsible development of drug candidate VXc-486 for tuberculosis.

Life-saving drug stopped by sole supplier (post with simple image)

South Africa is running out of an essential medicine for treating very sick patients with tuberculosis (TB) and drug-resistant bacterial infections. Many hospitals are already out of stock.

Intravenous rifampicin reintroduced in South Africa (post with simple image)

Equity Pharmaceuticals is the new supplier of the drug.

Page 9 of 11 · Total posts: 0

←First 8 9 10 Last→